RxDoctor Payments Data

Sie Thomas

Family · Dallas, TXNPI 1164582011

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $180,298 of the $197,376 with a category attached, or 91.3%. AbbVie accounts for 99.7% of it on its own, with 3 other manufacturers making up the rest. Among family clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$197,377in general payments, 2019–2025

Across 346 payments — averaging $570.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$197K
  • Merz North America, Inc.$312
  • Revance Therapeutics, Inc.$126
  • Galderma Laboratories, L.p.$75

What the payments were for

  • Speaking & faculty fees$180,29891%
  • Travel & lodging$10,7245%
  • Food & beverage$6,3383%
  • Education$170%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)328$196,864
Merz North America, Inc.12$312
Revance Therapeutics, Inc.3$126
Galderma Laboratories, L.p.3$75

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$197,377 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.

See all family providers in Texas →

Other family in Dallas

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →